Lilli Anselm

879 total citations
8 papers, 766 citations indexed

About

Lilli Anselm is a scholar working on Physical and Theoretical Chemistry, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Lilli Anselm has authored 8 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physical and Theoretical Chemistry, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Hematology. Recurrent topics in Lilli Anselm's work include Crystallography and molecular interactions (3 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Lilli Anselm is often cited by papers focused on Crystallography and molecular interactions (3 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Lilli Anselm collaborates with scholars based in Switzerland, China and Germany. Lilli Anselm's co-authors include David W. Banner, Bernd Kuhn, Jörg Benz, Wolfgang Haap, M. Stihle, Ralf Thoma, Bernard Gsell, Guido Hartmann, François Diederich and Joachim Diez and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Lilli Anselm

8 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lilli Anselm Switzerland 8 369 305 217 148 129 8 766
Xiuhua Yan China 7 416 1.1× 272 0.9× 207 1.0× 201 1.4× 153 1.2× 8 793
Leo A. Hardegger Switzerland 8 390 1.1× 324 1.1× 195 0.9× 180 1.2× 129 1.0× 9 743
Joachim Diez Switzerland 10 366 1.0× 245 0.8× 432 2.0× 146 1.0× 195 1.5× 14 1.1k
Matthias Urmann Germany 16 195 0.5× 390 1.3× 322 1.5× 117 0.8× 107 0.8× 23 940
Volkmar Wehner Germany 14 212 0.6× 313 1.0× 303 1.4× 110 0.7× 110 0.9× 26 769
Matthew R. Scholfield United States 6 436 1.2× 167 0.5× 189 0.9× 187 1.3× 175 1.4× 6 652
Ralph Paulini Switzerland 15 259 0.7× 479 1.6× 482 2.2× 107 0.7× 198 1.5× 16 1.1k
Elke Persch Switzerland 7 201 0.5× 332 1.1× 250 1.2× 117 0.8× 227 1.8× 7 800
Aneta Jezierska Poland 18 363 1.0× 483 1.6× 178 0.8× 78 0.5× 158 1.2× 104 1.1k
Manoranjan Panda India 16 161 0.4× 459 1.5× 344 1.6× 171 1.2× 164 1.3× 29 910

Countries citing papers authored by Lilli Anselm

Since Specialization
Citations

This map shows the geographic impact of Lilli Anselm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilli Anselm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilli Anselm more than expected).

Fields of papers citing papers by Lilli Anselm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilli Anselm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilli Anselm. The network helps show where Lilli Anselm may publish in the future.

Co-authorship network of co-authors of Lilli Anselm

This figure shows the co-authorship network connecting the top 25 collaborators of Lilli Anselm. A scholar is included among the top collaborators of Lilli Anselm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilli Anselm. Lilli Anselm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Giroud, Maude, Lilli Anselm, David W. Banner, et al.. (2018). Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain andTrypanosoma bruceiInhibitors. Journal of Medicinal Chemistry. 61(8). 3350–3369. 31 indexed citations
2.
Hilpert, Hans, Harald Mauser, Lilli Anselm, et al.. (2013). Identification of Potent and Selective Cathepsin S Inhibitors Containing Different Central Cyclic Scaffolds. Journal of Medicinal Chemistry. 56(23). 9789–9801. 44 indexed citations
3.
Hardegger, Leo A., Bernd Kuhn, Lilli Anselm, et al.. (2011). Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments. ChemMedChem. 6(11). 2048–2054. 105 indexed citations
4.
Hardegger, Leo A., Bernd Kuhn, Lilli Anselm, et al.. (2010). Systematic Investigation of Halogen Bonding in Protein–Ligand Interactions. Angewandte Chemie International Edition. 50(1). 314–318. 423 indexed citations
5.
Anselm, Lilli, David W. Banner, Jörg Benz, et al.. (2010). Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidate. Bioorganic & Medicinal Chemistry Letters. 20(17). 5313–5319. 31 indexed citations
6.
Hardegger, Leo A., Bernd Kuhn, Lilli Anselm, et al.. (2010). Systematische Untersuchung von Halogenbrücken in Protein‐Ligand‐ Wechselwirkungen. Angewandte Chemie. 123(1). 329–334. 76 indexed citations
7.
Zbinden, Katrin Groebke, Lilli Anselm, David W. Banner, et al.. (2009). Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit. European Journal of Medicinal Chemistry. 44(7). 2787–2795. 31 indexed citations
8.
Alanine, Alexander, et al.. (2003). Synthesis and SAR evaluation of 1,2,4-triazoles as A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(3). 817–821. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026